Tokyo Tape
Sign in
← Eucalia

Half-year report · HY

286A.TEDINET S100YWR5
Period2026-01-01 → 2026-06-30
Filed2026-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥13.7bn2026-01-01 → 2026-06-30Cons.Net sales
Revenue¥24.7bn2025-01-01 → 2025-12-31Cons.Net sales (5-year summary)
Revenue¥10.5bn2025-01-01 → 2025-06-30Cons.Net sales
Operating income¥395m2026-01-01 → 2026-06-30Cons.Operating income
Operating income¥1.1bn2025-01-01 → 2025-06-30Cons.Operating income
Ordinary income¥361m2026-01-01 → 2026-06-30Cons.Ordinary income
Ordinary income¥2.1bn2025-01-01 → 2025-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥981m2025-01-01 → 2025-06-30Cons.Ordinary income
Profit before tax¥256m2026-01-01 → 2026-06-30Cons.Income before income taxes
Profit before tax¥1.2bn2025-01-01 → 2025-06-30Cons.Income before income taxes
Net income (owners)¥489m2026-01-01 → 2026-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.8bn2025-01-01 → 2025-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥824m2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent
Net income¥560m2026-01-01 → 2026-06-30Cons.Profit loss
Net income¥887m2025-01-01 → 2025-06-30Cons.Profit loss
Total assets¥67.5bnat 2026-06-30Cons.Assets
Total assets¥65.1bnat 2025-12-31Cons.Assets
Total assets¥61.2bnat 2025-06-30Cons.Total assets (5-year summary)
Total liabilities¥45.2bnat 2026-06-30Cons.Liabilities
Total liabilities¥43.3bnat 2025-12-31Cons.Liabilities
Net assets / equity¥22.3bnat 2026-06-30Cons.Net assets
Net assets / equity¥21.8bnat 2025-12-31Cons.Net assets
Net assets / equity¥19.7bnat 2025-06-30Cons.Net assets (5-year summary)
Cash and deposits¥11.0bnat 2026-06-30Cons.Cash and deposits
Cash and deposits¥9.1bnat 2025-12-31Cons.Cash and deposits
Cash & equivalents¥10.9bnat 2026-06-30Cons.Cash and cash equivalents
Cash & equivalents¥9.1bnat 2025-12-31Cons.Cash and cash equivalents
Cash & equivalents¥8.2bnat 2025-06-30Cons.Cash and cash equivalents
Cash & equivalents¥11.1bnat 2024-12-31vCons.Cash and cash equivalents
Operating cash flow¥551m2026-01-01 → 2026-06-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥1.9bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.6bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities
Investing cash flow¥92m2026-01-01 → 2026-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥2.3bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥2.4bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in investment activities
Financing cash flow¥1.2bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in financing activities
Financing cash flow¥1.8bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥856m2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥13.672026-01-01 → 2026-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥78.072025-01-01 → 2025-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥23.22025-01-01 → 2025-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥13.572026-01-01 → 2026-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥76.752025-01-01 → 2025-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥22.752025-01-01 → 2025-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio31.2%at 2026-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio31.5%at 2025-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio30.3%at 2025-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 50
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2026-01-01 → 2026-06-30¥376m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2026-01-01 → 2026-06-30¥376m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2026-01-01 → 2026-06-30¥118m
Reconciling Itemsreconcilingrevenue2026-01-01 → 2026-06-30−¥16m
Reconciling Itemsreconcilingrevenue intersegment2026-01-01 → 2026-06-30−¥16m
Reconciling Itemsreconcilingsegment profit2026-01-01 → 2026-06-30−¥731m
Comprehensive Medical Management Support Businessreportable segmentrevenue2026-01-01 → 2026-06-30¥5.1bn
Comprehensive Medical Management Support Businessreportable segmentrevenue external2026-01-01 → 2026-06-30¥5.0bn
Comprehensive Medical Management Support Businessreportable segmentrevenue intersegment2026-01-01 → 2026-06-30¥15m
Comprehensive Medical Management Support Businessreportable segmentsegment profit2026-01-01 → 2026-06-30¥457m
Elderly Care Related Businessreportable segmentrevenue2026-01-01 → 2026-06-30¥4.4bn
Elderly Care Related Businessreportable segmentrevenue external2026-01-01 → 2026-06-30¥4.4bn
Elderly Care Related Businessreportable segmentrevenue intersegment2026-01-01 → 2026-06-30¥740,000
Elderly Care Related Businessreportable segmentsegment profit2026-01-01 → 2026-06-30¥312m
Specially Controlled Medical Device Businessreportable segmentrevenue2026-01-01 → 2026-06-30¥3.8bn
Specially Controlled Medical Device Businessreportable segmentrevenue external2026-01-01 → 2026-06-30¥3.8bn
Specially Controlled Medical Device Businessreportable segmentsegment profit2026-01-01 → 2026-06-30¥240m
—segment totalrevenue2026-01-01 → 2026-06-30¥13.3bn
—segment totalrevenue external2026-01-01 → 2026-06-30¥13.3bn
—segment totalrevenue intersegment2026-01-01 → 2026-06-30¥16m
—segment totalsegment profit2026-01-01 → 2026-06-30¥1.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2026-01-01 → 2026-06-30¥13.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2026-01-01 → 2026-06-30¥13.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2026-01-01 → 2026-06-30¥16m
Total Of Reportable Segments And Otherssegment totalsegment profit2026-01-01 → 2026-06-30¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-01-01 → 2025-06-30¥219m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-01-01 → 2025-06-30¥219m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30¥41m
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-06-30−¥640,000
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-06-30−¥640,000
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30−¥670m
Comprehensive Medical Management Support Businessreportable segmentrevenue2025-01-01 → 2025-06-30¥3.1bn
Comprehensive Medical Management Support Businessreportable segmentrevenue external2025-01-01 → 2025-06-30¥3.1bn
Comprehensive Medical Management Support Businessreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥395,000
Comprehensive Medical Management Support Businessreportable segmentsegment profit2025-01-01 → 2025-06-30¥1.3bn
Elderly Care Related Businessreportable segmentrevenue2025-01-01 → 2025-06-30¥3.7bn
Elderly Care Related Businessreportable segmentrevenue external2025-01-01 → 2025-06-30¥3.7bn
Elderly Care Related Businessreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥245,000
Elderly Care Related Businessreportable segmentsegment profit2025-01-01 → 2025-06-30¥187m
Specially Controlled Medical Device Businessreportable segmentrevenue2025-01-01 → 2025-06-30¥3.6bn
Specially Controlled Medical Device Businessreportable segmentrevenue external2025-01-01 → 2025-06-30¥3.6bn
Specially Controlled Medical Device Businessreportable segmentsegment profit2025-01-01 → 2025-06-30¥276m
—segment totalrevenue2025-01-01 → 2025-06-30¥10.3bn
—segment totalrevenue external2025-01-01 → 2025-06-30¥10.3bn
—segment totalrevenue intersegment2025-01-01 → 2025-06-30¥640,000
—segment totalsegment profit2025-01-01 → 2025-06-30¥1.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2025-01-01 → 2025-06-30¥10.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-01-01 → 2025-06-30¥10.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2025-01-01 → 2025-06-30¥640,000
Total Of Reportable Segments And Otherssegment totalsegment profit2025-01-01 → 2025-06-30¥1.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 552
ItemContextValueUnit
Operating incomePrior1InterimDuration1134716000JPY
Operating incomeInterimDuration395132000JPY
Interest income noiPrior1InterimDuration15633000JPY
Interest income noiInterimDuration17771000JPY
Gain on sales of securities noiPrior1InterimDuration－JPY
Gain on sales of securities noiInterimDuration8832000JPY
Subsidy income noiPrior1InterimDuration8080000JPY
Subsidy income noiInterimDuration104992000JPY
Other noiPrior1InterimDuration16200000JPY
Other noiInterimDuration53213000JPY
Non operating incomePrior1InterimDuration39914000JPY
Non operating incomeInterimDuration184809000JPY
Interest expenses noePrior1InterimDuration165330000JPY
Interest expenses noeInterimDuration188830000JPY
Equity in losses of affiliates noePrior1InterimDuration－JPY
Equity in losses of affiliates noeInterimDuration10099000JPY
Other noePrior1InterimDuration28279000JPY
Other noeInterimDuration19968000JPY
Non operating expensesPrior1InterimDuration193609000JPY
Non operating expensesInterimDuration218898000JPY
Ordinary incomePrior1InterimDuration981021000JPY
Ordinary incomeInterimDuration361044000JPY
Gain on sales of noncurrent assets eiPrior1InterimDuration111103000JPY
Gain on sales of noncurrent assets eiInterimDuration4228000JPY
Gain on sales of investment securities eiPrior1InterimDuration－JPY
Gain on sales of investment securities eiInterimDuration20068000JPY
Gain on forgiveness of debts eiPrior1InterimDuration138172000JPY
Gain on forgiveness of debts eiInterimDuration－JPY
Extraordinary incomePrior1InterimDuration249276000JPY
Extraordinary incomeInterimDuration24297000JPY
Loss on sales of noncurrent assets elPrior1InterimDuration13608000JPY
Loss on sales of noncurrent assets elInterimDuration－JPY
Loss on retirement of noncurrent assets elPrior1InterimDuration－JPY
Loss on retirement of noncurrent assets elInterimDuration29672000JPY
Nonrecurring loss elPrior1InterimDuration－JPY
Nonrecurring loss elInterimDuration32482000JPY
Loss on cancellation of contracts elPrior1InterimDuration－JPY
Loss on cancellation of contracts elInterimDuration65790000JPY
Other elPrior1InterimDuration779000JPY
Other elInterimDuration935000JPY
Extraordinary lossPrior1InterimDuration14387000JPY
Extraordinary lossInterimDuration128880000JPY
Income before income taxesPrior1InterimDuration1215910000JPY
Income before income taxesInterimDuration256461000JPY
Income taxes currentPrior1InterimDuration359787000JPY
Income taxes currentInterimDuration171855000JPY
Income taxes deferredPrior1InterimDuration-31323000JPY
Income taxes deferredInterimDuration-475704000JPY
Income taxesPrior1InterimDuration328463000JPY
Income taxesInterimDuration-303849000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-12-31pass
balance sheet identityconsolidated 2026-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-12-31pass
statement vs summary · net assetsconsolidated 2026-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · net income attributable to parentconsolidated 2026-01-01/2026-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2026-01-01/2026-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2026-01-01/2026-06-30pass
statement vs summary · total assetsconsolidated 2025-12-31pass
statement vs summary · total assetsconsolidated 2026-06-30pass